RNA
aptamers have garnered attention for diagnostic applications
due to their ability to recognize diverse targets. Oligomers of 42-mer
amyloid β-protein (Aβ42), whose accumulation is relevant
to the pathology of Alzheimer’s disease (AD), are among the
most difficult molecules for aptamer recognition because they are
prone to aggregate in heterogeneous forms. In addition to designing
haptens for in vitro selection of aptamers, the difficulties involved
in determining their effect on Aβ42 oligomerization impede aptamer
research. We previously developed three RNA aptamers (E22P-AbD4, -AbD31,
and -AbD43) with high affinity for protofibrils (PFs) derived from
a toxic Aβ42 dimer. Notably, these aptamers recognized diffuse
staining, which likely originated from PFs or higher-order oligomers
with curvilinear structures in a knock-in App
NL-G-F/NL-G-F
mouse, carrying the Arctic mutation that preferentially induced
the formation of PFs, in addition to a PS2Tg2576 mouse. To determine
which oligomeric sizes were mainly altered by the aptamer, ion mobility–mass
spectrometry (IM–MS) was carried out. One aptamer, E22P-AbD43,
formed adducts with the Aβ42 monomer and dimer, leading to suppression
of further oligomerization. These findings support the utility of
these aptamers as diagnostics for AD.